Lalla D - Search Results

1

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.

Krueger GG, Langley RG, Finlay AY, Griffiths CE, Woolley JM, Lalla D, Jahreis A. Krueger GG, et al. Among authors: lalla d. Br J Dermatol. 2005 Dec;153(6):1192-9. doi: 10.1111/j.1365-2133.2005.06948.x. Br J Dermatol. 2005. PMID: 16307657 Clinical Trial.

2

Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial.

Feldman SR, Kimball AB, Krueger GG, Woolley JM, Lalla D, Jahreis A. Feldman SR, et al. Among authors: lalla d. J Am Acad Dermatol. 2005 Nov;53(5):887-9. doi: 10.1016/j.jaad.2005.06.053. J Am Acad Dermatol. 2005. PMID: 16243150 Clinical Trial.

3

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R. Tyring S, et al. Among authors: lalla d. Lancet. 2006 Jan 7;367(9504):29-35. doi: 10.1016/S0140-6736(05)67763-X. Lancet. 2006. PMID: 16399150 Clinical Trial.

4

Clinical and economic burden of psoriasis.

Hazard E, Cherry SB, Lalla D, Woolley JM, Wilfehrt H, Chiou CF. Hazard E, et al. Among authors: lalla d. Manag Care Interface. 2006 Apr;19(4):20-6. Manag Care Interface. 2006. PMID: 16689023 Review.

5

Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer.

Welslau M, Diéras V, Sohn JH, Hurvitz SA, Lalla D, Fang L, Althaus B, Guardino E, Miles D. Welslau M, et al. Among authors: lalla d. Cancer. 2014 Mar 1;120(5):642-51. doi: 10.1002/cncr.28465. Epub 2013 Nov 12. Cancer. 2014. PMID: 24222194 Free article. Clinical Trial.

6

An economic model for a novel viral influenza diagnostic.

Kozma CM, Reeder CE, Seeney CE, Livingston PG, Lalla D. Kozma CM, et al. Among authors: lalla d. Manag Care Interface. 1998 Mar;11(3):86-93. Manag Care Interface. 1998. PMID: 10181542

7

Effect of trastuzumab on health-related quality of life in patients with HER2-positive metastatic breast cancer: data from three clinical trials.

Rugo H, Brammer M, Zhang F, Lalla D. Rugo H, et al. Among authors: lalla d. Clin Breast Cancer. 2010 Aug 1;10(4):288-93. doi: 10.3816/CBC.2010.n.037. Clin Breast Cancer. 2010. PMID: 20705561

8

Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011.

Lubeck DP, Danese MD, Duryea J, Halperin M, Tayama D, Yu E, Lalla D, Grotta JC. Lubeck DP, et al. Among authors: lalla d. Int J Stroke. 2016 Feb;11(2):198-205. doi: 10.1177/1747493015609776. Int J Stroke. 2016. PMID: 26783311

9

The Lifetime Economic Burden of Inaccurate HER2 Testing: Estimating the Costs of False-Positive and False-Negative HER2 Test Results in US Patients with Early-Stage Breast Cancer.

Garrison LP Jr, Babigumira JB, Masaquel A, Wang BC, Lalla D, Brammer M. Garrison LP Jr, et al. Among authors: lalla d. Value Health. 2015 Jun;18(4):541-6. doi: 10.1016/j.jval.2015.01.012. Epub 2015 May 16. Value Health. 2015. PMID: 26091608 Free article.

10

Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura.

McMillan R, Bussel JB, George JN, Lalla D, Nichol JL. McMillan R, et al. Among authors: lalla d. Am J Hematol. 2008 Feb;83(2):150-4. doi: 10.1002/ajh.20992. Am J Hematol. 2008. PMID: 17722072 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters